CRI Lifetree

Marlton, New Jersey 08054

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Healthy, Major Depressive Disorder, Mental Disorder, Mild Cognitive Impairment, Nervous System Diseases, Psychosis, Psychotic Depression, Schizoaffective Disorder, Schizophrenia, Severe Major Depression With Psychotic Features

Studies at this site

• Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease — Stopped early
• A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) — Stopped early
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features — Stopped early
• Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants — Completed
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia — Completed
• Bioavailability of LY03004 and Risperdal® Consta® — Completed
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant — Completed